{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T13:25:35Z","timestamp":1768915535262,"version":"3.49.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"21","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.vaccine.2018.04.037","type":"journal-article","created":{"date-parts":[[2018,4,30]],"date-time":"2018-04-30T06:07:15Z","timestamp":1525068435000},"page":"2960-2967","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Effectiveness of inactivated influenza vaccine against laboratory-confirmed influenza pneumonia among adults aged \u226565\u202fyears in Japan"],"prefix":"10.1016","volume":"36","author":[{"given":"Motoi","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoko","family":"Katsurada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minh Nhat","family":"Le","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norihiro","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makito","family":"Yaegashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoto","family":"Hosokawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihito","family":"Otsuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Aoshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lay Myint","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konosuke","family":"Morimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.04.037_b0005","doi-asserted-by":"crossref","first-page":"f5061","DOI":"10.1136\/bmj.f5061","article-title":"Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis","volume":"347","author":"Mertz","year":"2013","journal-title":"Bmj"},{"key":"10.1016\/j.vaccine.2018.04.037_b0010","doi-asserted-by":"crossref","first-page":"e0122247","DOI":"10.1371\/journal.pone.0122247","article-title":"The burden and etiology of community-onset pneumonia in the aging Japanese population: a multicenter prospective study","volume":"10","author":"Morimoto","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2018.04.037_b0015","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S1473-3099(11)70295-X","article-title":"Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis","volume":"12","author":"Osterholm","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2018.04.037_b0020","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S1473-3099(16)00129-8","article-title":"Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies","volume":"16","author":"Belongia","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2018.04.037_b0025","unstructured":"WHO. WHO vaccine-preventable diseases: monitoring system; 2017."},{"key":"10.1016\/j.vaccine.2018.04.037_b0030","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1474-9728.2004.00102.x","article-title":"Innate immunity in aging: impact on macrophage function","volume":"3","author":"Plowden","year":"2004","journal-title":"Aging Cell"},{"key":"10.1016\/j.vaccine.2018.04.037_b0035","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.4161\/hv.24696","article-title":"The effect of ageing of the immune system on vaccination responses","volume":"9","author":"Lord","year":"2013","journal-title":"Hum Vaccines Immunotherap"},{"key":"10.1016\/j.vaccine.2018.04.037_b0040","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S2213-2600(17)30043-7","article-title":"Effectiveness of seasonal influenza vaccination in community-dwelling elderly people: an individual participant data meta-analysis of test-negative design case-control studies","volume":"5","author":"Darvishian","year":"2017","journal-title":"Lancet Resp Med"},{"key":"10.1016\/j.vaccine.2018.04.037_b0045","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jinf.2017.09.010","article-title":"Effectiveness of influenza vaccines in preventing severe influenza illness among adults: a systematic review and meta-analysis of test-negative design case-control studies","volume":"75","author":"Rondy","year":"2017","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2018.04.037_b0050","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1001\/jama.2015.12160","article-title":"Association between hospitalization with community-acquired laboratory-confirmed influenza pneumonia and prior receipt of influenza vaccination","volume":"314","author":"Grijalva","year":"2015","journal-title":"Jama"},{"key":"10.1016\/j.vaccine.2018.04.037_b0055","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12890-016-0359-1","article-title":"Recurrent pneumonia among Japanese adults: disease burden and risk factors","volume":"17","author":"Ishifuji","year":"2017","journal-title":"BMC Pulmonary Med"},{"key":"10.1016\/j.vaccine.2018.04.037_b0060","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S1473-3099(17)30049-X","article-title":"Serotype-specific effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumococcal pneumonia in adults aged 65 years or older: a multicentre, prospective, test-negative design study","volume":"17","author":"Suzuki","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2018.04.037_b0065","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1186\/s12879-017-2858-y","article-title":"The impact of virus infections on pneumonia mortality is complex in adults: a prospective multicentre observational study","volume":"17","author":"Katsurada","year":"2017","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2018.04.037_b0070","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/INF.0b013e3181af61e9","article-title":"Viral pathogens associated with acute respiratory infections in central vietnamese children","volume":"29","author":"Yoshida","year":"2010","journal-title":"Pediatric Infect Dis J"},{"key":"10.1016\/j.vaccine.2018.04.037_b0075","doi-asserted-by":"crossref","first-page":"e88813","DOI":"10.1371\/journal.pone.0088813","article-title":"Vaccine effectiveness against medically attended laboratory-confirmed influenza in Japan, 2011\u20132012 Season","volume":"9","author":"Suzuki","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2018.04.037_b0080","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/irv.12244","article-title":"Impact of 2009 pandemic influenza among Vietnamese children based on a population-based prospective surveillance from 2007 to 2011","volume":"8","author":"Le","year":"2014","journal-title":"Influenza Other Resp Viruses"},{"key":"10.1016\/j.vaccine.2018.04.037_b0085","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/ije\/dym021","article-title":"Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness","volume":"36","author":"Orenstein","year":"2007","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.vaccine.2018.04.037_b0090","doi-asserted-by":"crossref","unstructured":"De Serres G, Skowronski DM, Wu XW, Ambrose CS. The test-negative design: validity, accuracy and precision of vaccine efficacy estimates compared to the gold standard of randomised placebo-controlled clinical trials. Euro surveillance: bulletin Europeen sur les maladies transmissibles = Eur Communicable Dis Bull 2013;18.","DOI":"10.2807\/1560-7917.ES2013.18.37.20585"},{"key":"10.1016\/j.vaccine.2018.04.037_b0095","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/aje\/kww064","article-title":"Theoretical basis of the test-negative study design for assessment of influenza vaccine effectiveness","volume":"184","author":"Sullivan","year":"2016","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2018.04.037_b0100","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.vaccine.2016.11.024","article-title":"Negative impact of prior influenza vaccination on current influenza vaccination among people infected and not infected in prior season: a test-negative case-control study in Japan","volume":"35","author":"Saito","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.04.037_b0105","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the Eastern Cooperative Oncology Group","volume":"5","author":"Oken","year":"1982","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.vaccine.2018.04.037_b0110","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1017\/S0950268814000107","article-title":"Potential effect of virus interference on influenza vaccine effectiveness estimates in test-negative designs","volume":"142","author":"Suzuki","year":"2014","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2018.04.037_b0115","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001269.pub4","article-title":"Vaccines for preventing influenza in the elderly","author":"Jefferson","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.vaccine.2018.04.037_b0120","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12979-017-0098-z","article-title":"Influenza vaccine response in community-dwelling German prefrail and frail individuals","volume":"14","author":"Bauer","year":"2017","journal-title":"Immun Ageing: I & A"},{"key":"10.1016\/j.vaccine.2018.04.037_b0125","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.vaccine.2005.08.105","article-title":"Antibody response to influenza vaccination in the elderly: a quantitative review","volume":"24","author":"Goodwin","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.04.037_b0130","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/oxfordjournals.aje.a116495","article-title":"Influenza vaccine effectiveness in preventing hospitalization for pneumonia in the elderly","volume":"136","author":"Foster","year":"1992","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2018.04.037_b0135","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/aje\/154.2.155","article-title":"Influenza vaccine effectiveness among elderly nursing home residents: a cohort study","volume":"154","author":"Monto","year":"2001","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2018.04.037_b0140","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1056\/NEJMoa070844","article-title":"Effectiveness of influenza vaccine in the community-dwelling elderly","volume":"357","author":"Nichol","year":"2007","journal-title":"New Engl J Med"},{"key":"10.1016\/j.vaccine.2018.04.037_b0145","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/infdis\/jix282","article-title":"The importance of frailty in the assessment of influenza vaccine effectiveness against influenza-related hospitalization in elderly people","volume":"216","author":"Andrew","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.04.037_b0150","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1128\/JCM.05841-11","article-title":"Yield of sputum for viral detection by reverse transcriptase PCR in adults hospitalized with respiratory illness","volume":"50","author":"Falsey","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2018.04.037_b0155","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1002\/jmv.23937","article-title":"Comparison of sputum and nasopharyngeal swabs for detection of respiratory viruses","volume":"86","author":"Jeong","year":"2014","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2018.04.037_b0160","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3389\/fcimb.2017.00338","article-title":"Mechanisms of severe mortality-associated bacterial co-infections following influenza virus infection","volume":"7","author":"Jia","year":"2017","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.vaccine.2018.04.037_b0165","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jaut.2017.03.011","article-title":"Vaccination recommendations for the adult immunosuppressed patient: a systematic review and comprehensive field synopsis","volume":"80","author":"Lopez","year":"2017","journal-title":"J Autoimmun"},{"key":"10.1016\/j.vaccine.2018.04.037_b0170","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008983.pub2","article-title":"Influenza vaccines in immunosuppressed adults with cancer","author":"Eliakim-Raz","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.vaccine.2018.04.037_b0175","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1093\/infdis\/jiv456","article-title":"Influence of statins on influenza vaccine response in elderly individuals","volume":"213","author":"Black","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.04.037_b0180","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1093\/infdis\/jiv457","article-title":"Impact of statins on influenza vaccine effectiveness against medically attended acute respiratory illness","volume":"213","author":"Omer","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.04.037_b0185","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1093\/infdis\/jiw335","article-title":"Effect of statin use on influenza vaccine effectiveness","volume":"214","author":"McLean","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.04.037_b0190","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1093\/infdis\/jiw055","article-title":"How regulatory T-cell induction by statins may impair influenza vaccine immunogenicity and effectiveness","volume":"213","author":"Mascitelli","year":"2016","journal-title":"J Infect Dis"},{"issue":"656","key":"10.1016\/j.vaccine.2018.04.037_b0195","first-page":"e7","article-title":"The effect of statins on mortality from severe infections and sepsis: a systematic review and meta-analysis","volume":"25","author":"Janda","year":"2010","journal-title":"J Crit Care"},{"key":"10.1016\/j.vaccine.2018.04.037_b0200","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.amjmed.2012.04.011","article-title":"Is statin use associated with reduced mortality after pneumonia? A systematic review and meta-analysis","volume":"125","author":"Chopra","year":"2012","journal-title":"Am J Med"},{"key":"10.1016\/j.vaccine.2018.04.037_b0205","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1093\/cid\/ciw174","article-title":"Statin use and hospital length of stay among adults hospitalized with community-acquired pneumonia","volume":"62","author":"Havers","year":"2016","journal-title":"Clin Infect Dis: Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.vaccine.2018.04.037_b0210","first-page":"354","article-title":"Estimated influenza vaccination rates in Japan. [Nihon koshu eisei zasshi]","volume":"61","author":"Nobuhara","year":"2014","journal-title":"Jpn J Publ Health"},{"key":"10.1016\/j.vaccine.2018.04.037_b0215","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1093\/infdis\/jiw641","article-title":"Comparative effectiveness of high-dose versus standard-dose influenza vaccines among US medicare beneficiaries in preventing postinfluenza deaths during 2012\u20132013 and 2013\u20132014","volume":"215","author":"Shay","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.04.037_b0220","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S2213-2600(17)30235-7","article-title":"Comparative effectiveness of high-dose versus standard-dose influenza vaccination on numbers of US nursing home residents admitted to hospital: a cluster-randomised trial","volume":"5","author":"Gravenstein","year":"2017","journal-title":"Lancet Resp Med"},{"key":"10.1016\/j.vaccine.2018.04.037_b0225","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/EDE.0b013e3182953065","article-title":"Inactivated influenza vaccines for prevention of community-acquired pneumonia: the limits of using nonspecific outcomes in vaccine effectiveness studies","volume":"24","author":"Ferdinands","year":"2013","journal-title":"Epidemiology"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18305206?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18305206?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:25:28Z","timestamp":1759400728000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18305206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":45,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0264410X18305206"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.04.037","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of inactivated influenza vaccine against laboratory-confirmed influenza pneumonia among adults aged \u226565\u202fyears in Japan","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.04.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}